Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects
Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both “fre...
Saved in:
Published in | Molecular and cellular endocrinology Vol. 219; no. 1; pp. 9 - 15 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
30.04.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both “fresh” fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1β (IL-1β) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (
P<0.05), and 28% lower in obese subjects, albeit non-significant (
P=0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean:
P<0.01; obese:
P<0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1β suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels. |
---|---|
AbstractList | Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both “fresh” fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1β (IL-1β) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (
P<0.05), and 28% lower in obese subjects, albeit non-significant (
P=0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean:
P<0.01; obese:
P<0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1β suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels. Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both 'fresh' fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1 beta (IL-1 beta ) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P<0.05), and 28% lower in obese subjects, albeit non-significant (P=0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P<0.01; obese: P<0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1 beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels. Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels. Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels. |
Author | Bruun, Jens M Jensen, Peter F Richelsen, Bjørn Lihn, Aina S He, Gengsheng Pedersen, Steen B |
Author_xml | – sequence: 1 givenname: Aina S surname: Lihn fullname: Lihn, Aina S email: lihn@dadlnet.dk organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark – sequence: 2 givenname: Jens M surname: Bruun fullname: Bruun, Jens M organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark – sequence: 3 givenname: Gengsheng surname: He fullname: He, Gengsheng organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark – sequence: 4 givenname: Steen B surname: Pedersen fullname: Pedersen, Steen B organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark – sequence: 5 givenname: Peter F surname: Jensen fullname: Jensen, Peter F organization: Department of Surgical Gastroenterology L, Aarhus Kommunehospital, Aarhus University Hospital, DK-8000 Aarhus C, Denmark – sequence: 6 givenname: Bjørn surname: Richelsen fullname: Richelsen, Bjørn organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15149722$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1r3DAQhkVJ6O6m_QG9BJ96szP68EqmpxCapLAkEJJLL0KWR6DFtjaSnbb_Plp2S6GH5DSHeZ6ReN8VORnDiIR8oVBRoOuLbTVYrBiAqIBXAOwDWVIlWamglidkCRx4KRnIBVmltAUAWTP1kSxoTUUjGVuSn5vwC2OBv3cRU_JhLIIrTOd3-SU7-bEYHu4uizxffLIYTX9YJiwmn9KM-1WPZizM2BWhxbxIc7vNbvpETp3pE34-zjPydP398eq23Nzf_Li63JRWiPVUNihaabmqW-YUum5tG-mUsmigYYrKes2lg7qpUSFzvOHGWKWk6xR2rWKKn5Gvh7u7GJ5nTJMe9n_tezNimJOWtBFMNPW7IKOUMxAig-dHcG4H7PQu-sHEP_pvbBmgB8DGkFJE9w8Bva9Gb3WuRu-r0cB1riY78j_H-slMOfIpGt-_aX47mJhTfPEYdbIeR4udjzlo3QX_hv0KSLCoJQ |
CitedBy_id | crossref_primary_10_1111_jpn_13802 crossref_primary_10_1016_j_metabol_2011_03_019 crossref_primary_10_1210_jc_2007_0397 crossref_primary_10_1016_j_tem_2016_03_012 crossref_primary_10_1016_j_metabol_2015_11_011 crossref_primary_10_1016_j_atherosclerosis_2007_06_027 crossref_primary_10_3390_nu14204324 crossref_primary_10_1089_dia_2014_0026 crossref_primary_10_3389_fendo_2015_00001 crossref_primary_10_1038_oby_2008_275 crossref_primary_10_1111_jpi_12257 crossref_primary_10_15171_npj_2017_19 crossref_primary_10_1016_j_bbi_2024_12_029 crossref_primary_10_1186_s12881_015_0174_1 crossref_primary_10_3390_nu15234858 crossref_primary_10_1038_ijo_2014_192 crossref_primary_10_1038_oby_2006_92 crossref_primary_10_1038_oby_2007_231 crossref_primary_10_1038_sj_ijo_0802883 crossref_primary_10_1007_s00125_008_1031_y crossref_primary_10_1210_jc_2005_2786 crossref_primary_10_1515_jpm_2015_0259 crossref_primary_10_2527_2005_833565x crossref_primary_10_1016_S1499_2671_06_01006_9 crossref_primary_10_1111_j_1365_2362_2008_02028_x crossref_primary_10_1016_j_crvi_2006_03_020 crossref_primary_10_3390_medicina57070653 crossref_primary_10_1111_j_1365_2265_2010_03883_x crossref_primary_10_1245_s10434_015_4432_4 crossref_primary_10_1292_jvms_15_0233 crossref_primary_10_1155_2012_678381 crossref_primary_10_1210_jc_2009_0980 crossref_primary_10_1038_sj_ijo_0803745 crossref_primary_10_1111_j_1365_2796_2004_01426_x crossref_primary_10_3390_ijms18050959 crossref_primary_10_1210_jc_2005_2775 crossref_primary_10_1016_j_dld_2014_07_016 crossref_primary_10_2337_db08_1019 crossref_primary_10_1152_ajpendo_00419_2004 crossref_primary_10_1038_nutd_2017_10 crossref_primary_10_1371_journal_pone_0146840 crossref_primary_10_1016_j_jocd_2015_10_004 crossref_primary_10_1016_j_canlet_2012_11_038 crossref_primary_10_1016_j_bbrc_2013_07_034 crossref_primary_10_1186_1476_511X_10_11 crossref_primary_10_3390_ijerph17093287 crossref_primary_10_1016_j_hnm_2023_200210 crossref_primary_10_1038_oby_2007_80 crossref_primary_10_1016_j_bbalip_2015_02_003 crossref_primary_10_1186_s12917_019_2065_8 crossref_primary_10_1016_j_jcte_2021_100257 crossref_primary_10_1007_BF03345790 crossref_primary_10_1038_oby_2005_262 crossref_primary_10_3390_nu15173806 crossref_primary_10_1007_BF03347056 crossref_primary_10_1038_sj_hdy_6801089 crossref_primary_10_1007_BF03174067 crossref_primary_10_1007_s00125_005_0038_x crossref_primary_10_1038_oby_2006_5 crossref_primary_10_1371_journal_pone_0103093 crossref_primary_10_1016_j_orcp_2019_09_006 crossref_primary_10_1002_jcb_21980 crossref_primary_10_1016_j_tvjl_2016_08_002 crossref_primary_10_1038_oby_2005_74 crossref_primary_10_5402_2011_592404 crossref_primary_10_1016_j_atherosclerosis_2010_03_022 crossref_primary_10_1016_j_metabol_2008_12_009 crossref_primary_10_1111_j_1440_1797_2008_01018_x crossref_primary_10_2147_DMSO_S271509 crossref_primary_10_1002_art_40102 crossref_primary_10_1038_oby_2007_556 crossref_primary_10_1007_s00125_006_0335_z crossref_primary_10_1210_jc_2006_1268 crossref_primary_10_1007_s10354_010_0781_6 crossref_primary_10_2217_imt_13_142 crossref_primary_10_1194_jlr_M600272_JLR200 crossref_primary_10_1016_j_cca_2007_04_006 crossref_primary_10_1007_s11695_008_9701_x crossref_primary_10_1186_s12933_018_0734_8 crossref_primary_10_1016_j_ijgo_2008_10_006 crossref_primary_10_1038_ijo_2010_98 crossref_primary_10_1111_jgh_14778 crossref_primary_10_1016_j_gene_2019_03_070 crossref_primary_10_1016_j_molmed_2005_06_010 crossref_primary_10_2217_dmt_11_22 crossref_primary_10_1016_j_regpep_2009_04_010 crossref_primary_10_1016_j_jss_2008_09_007 crossref_primary_10_4161_adip_21756 crossref_primary_10_1016_j_diabet_2008_04_001 crossref_primary_10_1038_s41598_024_76280_6 crossref_primary_10_1152_ajpendo_90359_2008 crossref_primary_10_1016_j_peptides_2014_10_006 crossref_primary_10_3389_fendo_2024_1439691 crossref_primary_10_1038_ijo_2016_128 crossref_primary_10_1210_er_2012_1041 crossref_primary_10_1038_s41598_019_47113_8 crossref_primary_10_1517_14656560802618811 crossref_primary_10_1038_ncpgasthep0186 crossref_primary_10_1097_01_mco_0000172571_41149_52 crossref_primary_10_1161_STROKEAHA_108_520106 crossref_primary_10_1080_08820139_2024_2302823 crossref_primary_10_1507_endocrj_EJ14_0262 crossref_primary_10_1016_j_metabol_2008_07_029 crossref_primary_10_18087_cardio_2020_4_n517 crossref_primary_10_1038_sj_ijo_0803676 crossref_primary_10_1210_jc_2007_1155 crossref_primary_10_1902_jop_2008_070433 crossref_primary_10_1371_journal_pone_0143779 crossref_primary_10_1038_sj_ijo_0803793 crossref_primary_10_1111_j_1365_2796_2004_01432_x crossref_primary_10_1038_oby_2008_482 crossref_primary_10_1111_cen_13984 crossref_primary_10_1080_17461391_2011_635701 crossref_primary_10_1007_s11695_016_2477_5 crossref_primary_10_1507_endocrj_K09E_091 crossref_primary_10_1007_s11695_007_9090_6 crossref_primary_10_1038_ejcn_2010_277 crossref_primary_10_1016_j_ijcard_2007_02_015 crossref_primary_10_1155_2012_386524 crossref_primary_10_1002_jcb_21782 crossref_primary_10_1007_s00125_007_0686_0 crossref_primary_10_1007_BF03401293 crossref_primary_10_2515_therapie_2007055 crossref_primary_10_1186_1476_511X_10_198 crossref_primary_10_4158_EP_2017_0086 crossref_primary_10_1210_jc_2004_1696 crossref_primary_10_3844_ajavsp_2010_228_232 crossref_primary_10_3389_fendo_2022_822962 crossref_primary_10_3390_biomedicines8050123 crossref_primary_10_1089_met_2007_0029 crossref_primary_10_1038_oby_2008_555 crossref_primary_10_3109_07435800_2014_920349 crossref_primary_10_1155_2012_389108 crossref_primary_10_1038_s41366_023_01406_1 crossref_primary_10_1038_ijo_2010_216 crossref_primary_10_1210_jc_2009_0431 crossref_primary_10_1038_oby_2005_206 crossref_primary_10_1016_j_semnephrol_2012_12_008 crossref_primary_10_2337_dbi19_0006 crossref_primary_10_1097_FJC_0000000000001131 crossref_primary_10_1590_2359_3997000000316 crossref_primary_10_1016_j_nutres_2013_02_005 crossref_primary_10_1371_journal_pone_0174115 crossref_primary_10_1111_head_12788 crossref_primary_10_1194_jlr_M500212_JLR200 crossref_primary_10_1016_j_hkjn_2012_09_002 crossref_primary_10_1210_jc_2006_0382 crossref_primary_10_1515_hmbci_2015_0042 crossref_primary_10_1155_2017_8494107 crossref_primary_10_1093_gerona_63_4_414 crossref_primary_10_1111_sji_12027 crossref_primary_10_1007_s12170_014_0411_8 crossref_primary_10_1177_0148607108326070 crossref_primary_10_1016_j_cca_2013_02_003 crossref_primary_10_1016_j_clnesp_2018_08_007 crossref_primary_10_1093_bjd_ljac107 crossref_primary_10_1186_1471_2350_10_39 crossref_primary_10_1186_1472_6823_14_7 crossref_primary_10_1002_oby_21028 crossref_primary_10_2337_db10_0483 crossref_primary_10_1152_ajpendo_00240_2005 crossref_primary_10_1007_s11695_008_9424_z crossref_primary_10_2337_diabetes_55_01_06_db05_1105 crossref_primary_10_1007_s00418_005_0014_z crossref_primary_10_1016_j_jaci_2012_09_008 crossref_primary_10_1111_j_1467_789X_2005_00159_x crossref_primary_10_1007_s00424_021_02596_1 crossref_primary_10_3390_antiox9111088 crossref_primary_10_1002_hep_22350 crossref_primary_10_1016_j_neuropharm_2014_12_023 crossref_primary_10_1016_j_dsx_2019_06_005 crossref_primary_10_1210_en_2009_0462 crossref_primary_10_1196_annals_1329_063 crossref_primary_10_1371_journal_pone_0119530 crossref_primary_10_1111_j_1365_2796_2005_01571_x crossref_primary_10_1186_s12906_016_1278_7 crossref_primary_10_4158_EP_13_7_790 crossref_primary_10_1016_j_atherosclerosis_2007_11_010 crossref_primary_10_1038_oby_2007_97 crossref_primary_10_1111_j_1365_2265_2007_02991_x crossref_primary_10_1038_oby_2007_263 crossref_primary_10_1097_MCO_0b013e32832c6db7 crossref_primary_10_1152_ajpheart_00907_2011 crossref_primary_10_3390_nu12051305 crossref_primary_10_1371_journal_pone_0084816 crossref_primary_10_18705_1607_419X_2019_25_5_568_576 crossref_primary_10_3389_fimmu_2020_01800 crossref_primary_10_1007_s10616_018_0238_0 crossref_primary_10_1038_sj_ijo_0803138 crossref_primary_10_1002_dmrr_2840 crossref_primary_10_1152_japplphysiol_01080_2011 crossref_primary_10_1038_ijo_2015_15 crossref_primary_10_1038_ijo_2008_163 crossref_primary_10_2527_jas_2008_0971 crossref_primary_10_1042_BJ20091045 crossref_primary_10_1016_j_neurobiolaging_2013_07_022 crossref_primary_10_1017_S2040174417000204 crossref_primary_10_1249_MSS_0000000000000670 crossref_primary_10_1038_oby_2010_23 crossref_primary_10_1007_s11434_014_0386_3 crossref_primary_10_1177_1559827607300283 crossref_primary_10_1530_EJE_07_0213 crossref_primary_10_1111_j_1749_6632_2010_05875_x crossref_primary_10_1016_j_diabet_2007_09_004 crossref_primary_10_1002_ana_22062 crossref_primary_10_1016_j_jacig_2022_02_003 crossref_primary_10_1152_ajpendo_00068_2015 crossref_primary_10_1007_s40620_014_0070_3 crossref_primary_10_3390_biology12101289 crossref_primary_10_1016_j_jacc_2021_02_070 crossref_primary_10_3923_javaa_2012_637_640 crossref_primary_10_1016_j_regpep_2013_03_027 crossref_primary_10_1038_oby_2009_442 crossref_primary_10_1097_QAD_0b013e3283021a4f crossref_primary_10_3389_fcvm_2020_00022 crossref_primary_10_1038_sj_ijo_0802983 crossref_primary_10_1007_s00421_011_2073_2 crossref_primary_10_1210_en_2011_0068 crossref_primary_10_3390_biology11111657 crossref_primary_10_18705_1607_419X_2012_18_2_164_176 crossref_primary_10_1152_ajpendo_00506_2005 crossref_primary_10_3389_fendo_2023_1097034 crossref_primary_10_1093_brain_awp208 crossref_primary_10_1016_j_steroids_2011_06_004 crossref_primary_10_1183_09031936_00047010 crossref_primary_10_2337_diacare_28_9_2181 crossref_primary_10_1016_j_trsl_2014_05_008 crossref_primary_10_3390_nu15153453 crossref_primary_10_1016_j_dsx_2013_02_027 crossref_primary_10_1016_j_immbio_2005_12_001 |
Cites_doi | 10.1016/S0026-0495(03)00092-1 10.1055/s-0029-1212086 10.1007/s00125-003-1074-z 10.1136/bmj.322.7288.716 10.2337/diabetes.50.9.2094 10.1016/S0006-291X(03)00090-1 10.1152/ajpendo.00206.2003 10.1530/eje.0.1480657 10.1152/ajpendo.00269.2003 10.1038/90984 10.1006/bbrc.1999.0842 10.1074/jbc.C200251200 10.2337/diacare.26.8.2442 10.1038/sj.ijo.0802367 10.1006/bbrc.2001.5904 10.1055/s-2002-38246 10.1056/NEJM199704103361506 10.1006/bbrc.2001.6307 10.1016/0026-0495(91)90078-B 10.1152/ajpendo.00358.2002 10.2337/diacare.26.6.1745 10.1161/01.CIR.100.25.2473 10.1161/01.ATV.20.6.1595 10.1016/S1043-2760(00)00301-5 10.1152/ajpendo.00110.2003 10.1074/jbc.271.18.10697 10.1161/01.CIR.102.11.1296 10.1093/ajcn/74.3.315 10.1006/bbrc.1999.0255 10.1055/s-2007-978679 10.1210/jc.2002-021600 10.1038/90992 10.1055/s-0037-1613860 10.1111/j.1749-6632.1999.tb07793.x 10.3109/07853899209164137 10.1055/s-2003-39078 10.1161/01.ATV.19.4.972 10.1006/bbrc.1996.0587 |
ContentType | Journal Article |
Copyright | 2004 Elsevier Ireland Ltd Copyright 2004 Elsevier Ltd. |
Copyright_xml | – notice: 2004 Elsevier Ireland Ltd – notice: Copyright 2004 Elsevier Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 7X8 |
DOI | 10.1016/j.mce.2004.03.002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | Nucleic Acids Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1872-8057 |
EndPage | 15 |
ExternalDocumentID | 15149722 10_1016_j_mce_2004_03_002 S030372070400098X |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29M 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABFNM ABFRF ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HLW HMK HMO HVGLF HZ~ IHE J1W J5H KOM LCYCR LX3 LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SBG SCC SCU SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K WH7 WUQ X7M ZGI ZXP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION CGR CUY CVF ECM EIF NPM PKN 7TM 7X8 |
ID | FETCH-LOGICAL-c446t-9e4b7c385b2f8efd6c97f88cea0928175637f0595e8e2f393aac887fd8edb8283 |
IEDL.DBID | .~1 |
ISSN | 0303-7207 |
IngestDate | Fri Jul 11 12:35:43 EDT 2025 Fri Jul 11 15:50:03 EDT 2025 Wed Feb 19 01:40:16 EST 2025 Thu Apr 24 22:54:57 EDT 2025 Tue Jul 01 03:48:13 EDT 2025 Fri Feb 23 02:19:21 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Obesity (Human) visceral adipose tissue (Human) subcutaneous adipose tissue IL-1β Gene expression Adiponectin |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright 2004 Elsevier Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c446t-9e4b7c385b2f8efd6c97f88cea0928175637f0595e8e2f393aac887fd8edb8283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15149722 |
PQID | 21132044 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_71942495 proquest_miscellaneous_21132044 pubmed_primary_15149722 crossref_primary_10_1016_j_mce_2004_03_002 crossref_citationtrail_10_1016_j_mce_2004_03_002 elsevier_sciencedirect_doi_10_1016_j_mce_2004_03_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-04-30 |
PublicationDateYYYYMMDD | 2004-04-30 |
PublicationDate_xml | – month: 04 year: 2004 text: 2004-04-30 day: 30 |
PublicationDecade | 2000 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Molecular and cellular endocrinology |
PublicationTitleAlternate | Mol Cell Endocrinol |
PublicationYear | 2004 |
Publisher | Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier Ireland Ltd |
References | Barnes, Karin (BIB4) 1997; 336 Kubota, Terauchi, Yamauchi, Kubota, Moroi, Matsui, Eto, Yamashita, Kamon, Satoh, Yano, Froguel, Nagai, Kimura, Kadowaki, Noda (BIB26) 2002; 277 Fried, Bunkin, Greenberg (BIB17) 1998; 83 Maeda, Okubo, Shimomura, Funahashi, Matsuzawa, Matsubara (BIB29) 1996; 221 Seidell, Perusse, Despres, Bouchard (BIB36) 2001; 74 Ouchi, Kihara, Arita, Okamoto, Maeda, Kuriyama, Hotta, Nishida, Takahashi, Muraguchi, Ohmoto, Nakamura, Yamashita, Funahashi, Matsuzawa (BIB34) 2000; 102 Berg, Combs, Du, Brownlee, Scherer (BIB5) 2001; 7 Lihn, Ostergard, Nyholm, Pedersen, Richelsen, Schmitz (BIB27) 2003; 284 Maeda, Takahashi, Funahashi, Kihara, Nishizawa, Kishida, Nagaretani, Matsuda, Komuro, Ouchi, Kuriyama, Hotta, Nakamura, Shimomura, Matsuzawa (BIB30) 2001; 50 Despres, Lemieux, Prud’homme (BIB12) 2001; 322 Fisher, McTernan, Valsamakis, Chetty, Harte, Anwar, Starcynski, Crocker, Barnett, McTernan, Kumar (BIB16) 2002; 34 Krakoff, Funahashi, Stehouwer, Schalkwijk, Tanaka, Matsuzawa, Kobes, Tataranni, Hanson, Knowler, Lindsay (BIB24) 2003; 26 Hotta, Funahashi, Arita, Takahashi, Matsuda, Okamoto, Iwahashi, Kuriyama, Ouchi, Maeda, Nishida, Kihara, Sakai, Nakajima, Hasegawa, Muraguchi, Ohmoto, Nakamura, Yamashita, Hanafusa, Matsuzawa (BIB22) 2000; 20 Arita, Kihara, Ouchi, Takahashi, Maeda, Miyagawa, Hotta, Shimomura, Nakamura, Miyaoka, Kuriyama, Nishida, Yamashita, Okubo, Matsubara, Muraguchi, Ohmoto, Funahashi, Matsuzawa (BIB3) 1999; 257 Yang, Chen, Lee, Lee, Chao, Huang, Chen, Tai, Chuang (BIB39) 2003; 27 Fasshauer, Kralisch, Klier, Lossner, Bluher, Klein, Paschke (BIB15) 2003; 301 Hotamisligil (BIB21) 1999; 107 He, Pedersen, Bruun, Lihn, Jensen, Richelsen (BIB19) 2003; 35 Altomonte, Harbaran, Richter, Dong (BIB2) 2003; 52 Bjorntorp (BIB6) 1992; 24 Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiott, K.M., Fain, J.N., Richelsen, B., 2004. Higher production of interleukin-8 in visceral compared to subcutaneous adipose tissue. Implications of non-adipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286, E8–E13. Ouchi, Kihara, Arita, Maeda, Kuriyama, Okamoto, Hotta, Nishida, Takahashi, Nakamura, Yamashita, Funahashi, Matsuzawa (BIB33) 1999; 100 Kristensen, Pedersen, Richelsen (BIB25) 1999; 259 Eriksson, Van, Hoffstedt, Lundquist, Vidal, Stemme, Hamsten, Arner, Reynisdottir (BIB13) 2000; 83 Cnop, Havel, Utzschneider, Carr, Sinha, Boyko, Retzlaff, Knopp, Brunzell, Kahn (BIB11) 2003; 46 Yudkin, Stehouwer, Emeis, Coppack (BIB40) 1999; 19 Ahima, Flier (BIB1) 2000; 11 Matsubara, Namioka, Katayose (BIB31) 2003; 148 Tong, Sankale, Hadigan, Tan, Rosenberg, Kanki, Grinspoon, Hotamisligil (BIB37) 2003; 88 Halleux, Takahashi, Delporte, Detry, Funahashi, Matsuzawa, Brichard (BIB18) 2001; 288 Matsuzawa, Funahashi, Nakamura (BIB32) 1999; 892 Hu, Liang, Spiegelman (BIB23) 1996; 271 Chandran, Phillips, Ciaraldi, Henry (BIB10) 2003; 26 Richelsen, Pedersen, Moller-Pedersen, Bak (BIB35) 1991; 40 He, Pedersen, Bruun, Richelsen (BIB20) 2000; 32 Bruun, Lihn, Verdich, Pedersen, Toubro, Astrup, Richelsen (BIB8) 2003; 285 Fasshauer, Klein, Neumann, Eszlinger, Paschke (BIB14) 2002; 290 Lihn, Richelsen, Pedersen, Haugaard, Rathje, Madsbad, Andersen (BIB28) 2003; 285 Bruun, Pedersen, Richelsen (BIB9) 2001; 86 Yamauchi, Kamon, Waki, Terauchi, Kubota, Hara, Mori, Ide, Murakami, Tsuboyama-Kasaoka, Ezaki, Akanuma, Gavrilova, Vinson, Reitman, Kagechika, Shudo, Yoda, Nakano, Tobe, Nagai, Kimura, Tomita, Froguel, Kadowaki (BIB38) 2001; 7 Ahima (10.1016/j.mce.2004.03.002_BIB1) 2000; 11 Halleux (10.1016/j.mce.2004.03.002_BIB18) 2001; 288 Tong (10.1016/j.mce.2004.03.002_BIB37) 2003; 88 10.1016/j.mce.2004.03.002_BIB7 Seidell (10.1016/j.mce.2004.03.002_BIB36) 2001; 74 Fisher (10.1016/j.mce.2004.03.002_BIB16) 2002; 34 Cnop (10.1016/j.mce.2004.03.002_BIB11) 2003; 46 Fasshauer (10.1016/j.mce.2004.03.002_BIB14) 2002; 290 He (10.1016/j.mce.2004.03.002_BIB19) 2003; 35 Kubota (10.1016/j.mce.2004.03.002_BIB26) 2002; 277 Hu (10.1016/j.mce.2004.03.002_BIB23) 1996; 271 Eriksson (10.1016/j.mce.2004.03.002_BIB13) 2000; 83 Krakoff (10.1016/j.mce.2004.03.002_BIB24) 2003; 26 Chandran (10.1016/j.mce.2004.03.002_BIB10) 2003; 26 Hotta (10.1016/j.mce.2004.03.002_BIB22) 2000; 20 Fried (10.1016/j.mce.2004.03.002_BIB17) 1998; 83 Yang (10.1016/j.mce.2004.03.002_BIB39) 2003; 27 Ouchi (10.1016/j.mce.2004.03.002_BIB33) 1999; 100 Despres (10.1016/j.mce.2004.03.002_BIB12) 2001; 322 Altomonte (10.1016/j.mce.2004.03.002_BIB2) 2003; 52 Kristensen (10.1016/j.mce.2004.03.002_BIB25) 1999; 259 Lihn (10.1016/j.mce.2004.03.002_BIB27) 2003; 284 Ouchi (10.1016/j.mce.2004.03.002_BIB34) 2000; 102 Hotamisligil (10.1016/j.mce.2004.03.002_BIB21) 1999; 107 Bjorntorp (10.1016/j.mce.2004.03.002_BIB6) 1992; 24 Maeda (10.1016/j.mce.2004.03.002_BIB29) 1996; 221 Barnes (10.1016/j.mce.2004.03.002_BIB4) 1997; 336 Berg (10.1016/j.mce.2004.03.002_BIB5) 2001; 7 Matsubara (10.1016/j.mce.2004.03.002_BIB31) 2003; 148 Yamauchi (10.1016/j.mce.2004.03.002_BIB38) 2001; 7 Maeda (10.1016/j.mce.2004.03.002_BIB30) 2001; 50 Lihn (10.1016/j.mce.2004.03.002_BIB28) 2003; 285 Richelsen (10.1016/j.mce.2004.03.002_BIB35) 1991; 40 Matsuzawa (10.1016/j.mce.2004.03.002_BIB32) 1999; 892 He (10.1016/j.mce.2004.03.002_BIB20) 2000; 32 Arita (10.1016/j.mce.2004.03.002_BIB3) 1999; 257 Bruun (10.1016/j.mce.2004.03.002_BIB9) 2001; 86 Fasshauer (10.1016/j.mce.2004.03.002_BIB15) 2003; 301 Bruun (10.1016/j.mce.2004.03.002_BIB8) 2003; 285 Yudkin (10.1016/j.mce.2004.03.002_BIB40) 1999; 19 |
References_xml | – volume: 11 start-page: 327 year: 2000 end-page: 332 ident: BIB1 article-title: Adipose tissue as an endocrine organ publication-title: Trends Endocrinol. Metab. – volume: 148 start-page: 657 year: 2003 end-page: 662 ident: BIB31 article-title: Decreased plasma adiponectin concentrations in women with low grade C-reactive protein elevation publication-title: Eur. J. Endocrinol. – volume: 19 start-page: 972 year: 1999 end-page: 978 ident: BIB40 article-title: C-reactive protein in healthy subjects—associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 83 start-page: 847 year: 1998 end-page: 850 ident: BIB17 article-title: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid publication-title: J. Clin. Endocrinol. Metab. – volume: 74 start-page: 315 year: 2001 end-page: 321 ident: BIB36 article-title: Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec family study publication-title: Am. J. Clin. Nutr. – volume: 7 start-page: 947 year: 2001 end-page: 953 ident: BIB5 article-title: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action publication-title: Nat. Med. – volume: 290 start-page: 1084 year: 2002 end-page: 1089 ident: BIB14 article-title: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes publication-title: Biochem. Biophys. Res. Commun. – volume: 7 start-page: 941 year: 2001 end-page: 946 ident: BIB38 article-title: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity publication-title: Nat. Med. – volume: 301 start-page: 1045 year: 2003 end-page: 1050 ident: BIB15 article-title: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes publication-title: Biochem. Biophys. Res. Commun. – volume: 259 start-page: 624 year: 1999 end-page: 630 ident: BIB25 article-title: Regulation of leptin by steroid hormones in rat adipose tissue publication-title: Biochem. Biophys. Res. Commun. – volume: 26 start-page: 2442 year: 2003 end-page: 2450 ident: BIB10 article-title: Adiponectin: more than just another fat cell hormone? publication-title: Diab. Care – volume: 107 start-page: 119 year: 1999 end-page: 125 ident: BIB21 article-title: Mechanisms of TNF-alpha-induced insulin resistance publication-title: Exp. Clin. Endocrinol. Diab. – volume: 24 start-page: 3 year: 1992 end-page: 5 ident: BIB6 article-title: Metabolic abnormalities in visceral obesity publication-title: Ann. Med. – volume: 285 start-page: E527 year: 2003 end-page: E533 ident: BIB8 article-title: Regulation of adiponectin by adipose tissue-derived cytokines: publication-title: Am. J. Physiol. Endocrinol. Metab. – volume: 277 start-page: 25863 year: 2002 end-page: 25866 ident: BIB26 article-title: Disruption of adiponectin causes insulin resistance and neointimal formation publication-title: J. Biol. Chem. – volume: 322 start-page: 716 year: 2001 end-page: 720 ident: BIB12 article-title: Treatment of obesity: need to focus on high risk abdominally obese patients publication-title: BMJ – volume: 88 start-page: 1559 year: 2003 end-page: 1564 ident: BIB37 article-title: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices publication-title: J. Clin. Endocrinol. Metab. – volume: 26 start-page: 1745 year: 2003 end-page: 1751 ident: BIB24 article-title: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian publication-title: Diabetes Care – volume: 35 start-page: 178 year: 2003 end-page: 182 ident: BIB19 article-title: Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects publication-title: Horm. Metab. Res. – volume: 271 start-page: 10697 year: 1996 end-page: 10703 ident: BIB23 article-title: AdipoQ is a novel adipose-specific gene dysregulated in obesity publication-title: J. Biol. Chem. – volume: 83 start-page: 545 year: 2000 end-page: 548 ident: BIB13 article-title: Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals publication-title: Thromb. Haemost. – volume: 40 start-page: 990 year: 1991 end-page: 996 ident: BIB35 article-title: Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2 publication-title: Metabolism – volume: 100 start-page: 2473 year: 1999 end-page: 2476 ident: BIB33 article-title: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin publication-title: Circulation – volume: 892 start-page: 146 year: 1999 end-page: 154 ident: BIB32 article-title: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances publication-title: Ann. NY Acad. Sci. – volume: 102 start-page: 1296 year: 2000 end-page: 1301 ident: BIB34 article-title: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway publication-title: Circulation – volume: 52 start-page: 958 year: 2003 end-page: 963 ident: BIB2 article-title: Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats publication-title: Metabolism – volume: 221 start-page: 286 year: 1996 end-page: 289 ident: BIB29 article-title: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) publication-title: Biochem. Biophys. Res. Commun. – volume: 27 start-page: 896 year: 2003 end-page: 900 ident: BIB39 article-title: Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women publication-title: Int. J. Obes. Relat. Metab. Disord. – volume: 34 start-page: 650 year: 2002 end-page: 654 ident: BIB16 article-title: Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status publication-title: Horm. Metab. Res. – volume: 20 start-page: 1595 year: 2000 end-page: 1599 ident: BIB22 article-title: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 257 start-page: 79 year: 1999 end-page: 83 ident: BIB3 article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity publication-title: Biochem. Biophys. Res. Commun. – volume: 86 start-page: 1267 year: 2001 end-page: 1273 ident: BIB9 article-title: Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro publication-title: J. Clin. Endocrinol. Metab. – volume: 50 start-page: 2094 year: 2001 end-page: 2099 ident: BIB30 article-title: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein publication-title: Diabetes – volume: 284 start-page: E443 year: 2003 end-page: E448 ident: BIB27 article-title: Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients publication-title: Am. J. Physiol. Endocrinol. Metab. – volume: 46 start-page: 459 year: 2003 end-page: 469 ident: BIB11 article-title: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex publication-title: Diabetologia – reference: Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiott, K.M., Fain, J.N., Richelsen, B., 2004. Higher production of interleukin-8 in visceral compared to subcutaneous adipose tissue. Implications of non-adipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286, E8–E13. – volume: 32 start-page: 515 year: 2000 end-page: 520 ident: BIB20 article-title: Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen publication-title: Horm. Metab. Res. – volume: 285 start-page: E1072 year: 2003 end-page: E1080 ident: BIB28 article-title: Increased expression of adipose tissue cytokines in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin publication-title: Am. J. Physiol. Endocrinol. Metab. – volume: 288 start-page: 1102 year: 2001 end-page: 1107 ident: BIB18 article-title: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue publication-title: Biochem. Biophys. Res. Commun. – volume: 336 start-page: 1066 year: 1997 end-page: 1071 ident: BIB4 article-title: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases publication-title: N. Engl. J. Med. – volume: 52 start-page: 958 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB2 article-title: Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats publication-title: Metabolism doi: 10.1016/S0026-0495(03)00092-1 – volume: 107 start-page: 119 year: 1999 ident: 10.1016/j.mce.2004.03.002_BIB21 article-title: Mechanisms of TNF-alpha-induced insulin resistance publication-title: Exp. Clin. Endocrinol. Diab. doi: 10.1055/s-0029-1212086 – volume: 46 start-page: 459 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB11 article-title: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex publication-title: Diabetologia doi: 10.1007/s00125-003-1074-z – volume: 322 start-page: 716 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB12 article-title: Treatment of obesity: need to focus on high risk abdominally obese patients publication-title: BMJ doi: 10.1136/bmj.322.7288.716 – volume: 50 start-page: 2094 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB30 article-title: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein publication-title: Diabetes doi: 10.2337/diabetes.50.9.2094 – volume: 301 start-page: 1045 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB15 article-title: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(03)00090-1 – volume: 285 start-page: E1072 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB28 article-title: Increased expression of adipose tissue cytokines in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00206.2003 – volume: 148 start-page: 657 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB31 article-title: Decreased plasma adiponectin concentrations in women with low grade C-reactive protein elevation publication-title: Eur. J. Endocrinol. doi: 10.1530/eje.0.1480657 – ident: 10.1016/j.mce.2004.03.002_BIB7 doi: 10.1152/ajpendo.00269.2003 – volume: 7 start-page: 941 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB38 article-title: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity publication-title: Nat. Med. doi: 10.1038/90984 – volume: 259 start-page: 624 year: 1999 ident: 10.1016/j.mce.2004.03.002_BIB25 article-title: Regulation of leptin by steroid hormones in rat adipose tissue publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1999.0842 – volume: 277 start-page: 25863 year: 2002 ident: 10.1016/j.mce.2004.03.002_BIB26 article-title: Disruption of adiponectin causes insulin resistance and neointimal formation publication-title: J. Biol. Chem. doi: 10.1074/jbc.C200251200 – volume: 26 start-page: 2442 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB10 article-title: Adiponectin: more than just another fat cell hormone? publication-title: Diab. Care doi: 10.2337/diacare.26.8.2442 – volume: 83 start-page: 847 year: 1998 ident: 10.1016/j.mce.2004.03.002_BIB17 article-title: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid publication-title: J. Clin. Endocrinol. Metab. – volume: 27 start-page: 896 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB39 article-title: Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women publication-title: Int. J. Obes. Relat. Metab. Disord. doi: 10.1038/sj.ijo.0802367 – volume: 288 start-page: 1102 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB18 article-title: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.2001.5904 – volume: 34 start-page: 650 year: 2002 ident: 10.1016/j.mce.2004.03.002_BIB16 article-title: Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status publication-title: Horm. Metab. Res. doi: 10.1055/s-2002-38246 – volume: 336 start-page: 1066 year: 1997 ident: 10.1016/j.mce.2004.03.002_BIB4 article-title: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199704103361506 – volume: 290 start-page: 1084 year: 2002 ident: 10.1016/j.mce.2004.03.002_BIB14 article-title: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.2001.6307 – volume: 40 start-page: 990 year: 1991 ident: 10.1016/j.mce.2004.03.002_BIB35 article-title: Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2 publication-title: Metabolism doi: 10.1016/0026-0495(91)90078-B – volume: 284 start-page: E443 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB27 article-title: Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00358.2002 – volume: 26 start-page: 1745 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB24 article-title: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian publication-title: Diabetes Care doi: 10.2337/diacare.26.6.1745 – volume: 100 start-page: 2473 year: 1999 ident: 10.1016/j.mce.2004.03.002_BIB33 article-title: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin publication-title: Circulation doi: 10.1161/01.CIR.100.25.2473 – volume: 20 start-page: 1595 year: 2000 ident: 10.1016/j.mce.2004.03.002_BIB22 article-title: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.20.6.1595 – volume: 11 start-page: 327 year: 2000 ident: 10.1016/j.mce.2004.03.002_BIB1 article-title: Adipose tissue as an endocrine organ publication-title: Trends Endocrinol. Metab. doi: 10.1016/S1043-2760(00)00301-5 – volume: 285 start-page: E527 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB8 article-title: Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00110.2003 – volume: 271 start-page: 10697 year: 1996 ident: 10.1016/j.mce.2004.03.002_BIB23 article-title: AdipoQ is a novel adipose-specific gene dysregulated in obesity publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.18.10697 – volume: 102 start-page: 1296 year: 2000 ident: 10.1016/j.mce.2004.03.002_BIB34 article-title: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway publication-title: Circulation doi: 10.1161/01.CIR.102.11.1296 – volume: 74 start-page: 315 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB36 article-title: Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec family study publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/74.3.315 – volume: 257 start-page: 79 year: 1999 ident: 10.1016/j.mce.2004.03.002_BIB3 article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1999.0255 – volume: 32 start-page: 515 year: 2000 ident: 10.1016/j.mce.2004.03.002_BIB20 article-title: Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen publication-title: Horm. Metab. Res. doi: 10.1055/s-2007-978679 – volume: 86 start-page: 1267 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB9 article-title: Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro publication-title: J. Clin. Endocrinol. Metab. – volume: 88 start-page: 1559 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB37 article-title: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2002-021600 – volume: 7 start-page: 947 year: 2001 ident: 10.1016/j.mce.2004.03.002_BIB5 article-title: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action publication-title: Nat. Med. doi: 10.1038/90992 – volume: 83 start-page: 545 year: 2000 ident: 10.1016/j.mce.2004.03.002_BIB13 article-title: Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals publication-title: Thromb. Haemost. doi: 10.1055/s-0037-1613860 – volume: 892 start-page: 146 year: 1999 ident: 10.1016/j.mce.2004.03.002_BIB32 article-title: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances publication-title: Ann. NY Acad. Sci. doi: 10.1111/j.1749-6632.1999.tb07793.x – volume: 24 start-page: 3 year: 1992 ident: 10.1016/j.mce.2004.03.002_BIB6 article-title: Metabolic abnormalities in visceral obesity publication-title: Ann. Med. doi: 10.3109/07853899209164137 – volume: 35 start-page: 178 year: 2003 ident: 10.1016/j.mce.2004.03.002_BIB19 article-title: Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects publication-title: Horm. Metab. Res. doi: 10.1055/s-2003-39078 – volume: 19 start-page: 972 year: 1999 ident: 10.1016/j.mce.2004.03.002_BIB40 article-title: C-reactive protein in healthy subjects—associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.19.4.972 – volume: 221 start-page: 286 year: 1996 ident: 10.1016/j.mce.2004.03.002_BIB29 article-title: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1996.0587 |
SSID | ssj0007528 |
Score | 2.251869 |
Snippet | Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 9 |
SubjectTerms | (Human) subcutaneous adipose tissue (Human) visceral adipose tissue Adiponectin Adipose Tissue - metabolism Adult Female Gene expression Gene Expression - drug effects Humans IL-1β Intercellular Signaling Peptides and Proteins - biosynthesis Intercellular Signaling Peptides and Proteins - genetics Interleukin-1 - pharmacology Middle Aged Obesity Obesity - genetics Obesity - metabolism RNA, Messenger - metabolism |
Title | Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects |
URI | https://dx.doi.org/10.1016/j.mce.2004.03.002 https://www.ncbi.nlm.nih.gov/pubmed/15149722 https://www.proquest.com/docview/21132044 https://www.proquest.com/docview/71942495 |
Volume | 219 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB5VRUJcELQ8QqH4gDggLdna3rV9jCqq8GgOQKWIi-X12lJQsonYpIILv50Z7y4Vh_TAaaX1WLI8o5lv7M8zAK9yVyIu9jpTIphMli5mGGdcVgpPt2ZU4IXeDl_OyumV_DAv5gdwPryFIVpl7_s7n568df9n3O_meLNYjL-geVKLFUVmmBs9pxfsUpGVv_19Q_NQReqvSsIZSQ83m4njtfKpUqbs6pzyfbFpH_ZMMejiAdzvwSObdOt7CAehOYLjSYOJ8-oXe80SnTOdkx_B3cv-1vwYvn2iVmgs_OxJrw1bR-bqxWbdkLtr2OrzbMLwe71oPZ1RdYNtYNukFhpaBtcw19RsXQUcaHcVHeC0j-Dq4t3X82nW91TIPCZ-28wEWSkvdFHxqEOsS29U1NoHlxuuEUuUQkWEXEXQgUdhhHMe_VCsdagrzM7EYzhscHVPgZVe8lQgv0YQc1ZFE6XTuoi6cL7OAx9BPuym9X3Bcep7sbQDs-y7RQVQI0xpc2FRASN483fKpqu2cZuwHFRk_zEZi9HgtmkvB3XaFW3rkljF611rMRcWPJdyv4Q6M5KadY_gSWcHN6tE4GkU58_-b1EncG-gBIn8ORxuf-zCC0Q72-o0mfMp3Jm8_zid_QF5V_x2 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tiwRcEOzyKK_1AXFACs3aTmIfqxWrAm0PsCtVXCzHsaWiNq027Qou_HZmnIQVh-6BU6R4Io08k5nP9ng-gLepzREXO5UUwutE5jYkmGdskgtHp2bU4IXuDk9n-fhSfp5n8wM46-_CUFllF_vbmB6jdfdm2M3mcLNYDL-hexLFSkFumGo1vwN3Jf6-RGPw4fdNnUeRRYJVkk5IvD_ajEVeKxdbZcq20Snfl5z2gc-YhM4fwcMOPbJRq-BjOPD1ERyPalw5r36xdyzWc8aN8iO4N-2OzY_h-4S40Jj_2VW91mwdmK0Wm3VN8a5mq6-zEcPn9aJxtEnVDjaebaNdaGjpbc1sXbF16XGg2ZW0g9M8gcvzjxdn46QjVUgcrvy2ifayLJxQWcmD8qHKnS6CUs7bVHOFYCIXRUDMlXnleRBaWOswEIVK-arE5Zl4Coc1avccWO4kjx3yK0Qxp2XQQVqlsqAy66rU8wGk_Wwa13UcJ-KLpelLy34YNAAxYUqTCoMGGMD7v59s2nYbtwnL3kTmH58xmA5u--ykN6dZ0bQuqax4vWsMLoYFT6XcL1Gcakls3QN41vrBjZaIPHXB-Yv_U-oE7o8vphMz-TT78hIe9PVBIn0Fh9urnX-N0Gdbvomu_Qc0a_4E |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lower+expression+of+adiponectin+mRNA+in+visceral+adipose+tissue+in+lean+and+obese+subjects&rft.jtitle=Molecular+and+cellular+endocrinology&rft.au=Lihn%2C+Aina+S&rft.au=Bruun%2C+Jens+M&rft.au=He%2C+Gengsheng&rft.au=Pedersen%2C+Steen+B&rft.date=2004-04-30&rft.issn=0303-7207&rft.volume=219&rft.issue=1-2&rft.spage=9&rft_id=info:doi/10.1016%2Fj.mce.2004.03.002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0303-7207&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0303-7207&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0303-7207&client=summon |